A company with roots in developing tools for translational research has raised $15.3 million to execute the first step of its pursuit of market share in diagnostics. When it was granted the CE Mark in ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The acquisition marks the close ...

Seattle's NanoString Technologies ($NSTG) stands to make up to $45 million if it can come up with a successful companion diagnostic test to screen for a subset of ...

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced that it has closed its asset acquisition of the business of NanoString Technologies, Inc., headquartered in Seattle ...

* Nanostring technologies-‍under terms of deal, lam will provide up to $50 million of funding intended to cover costs of development and regulatory approval * Nanostring technologies inc - ‍lam will ...

NanoString, which has been acquired by Bruker, has won a victory in a patent battle with 10x Genomics. Billerica, MA-based Bruker said that the German Federal Patent Court has ruled in favor of ...

In an order posted to the site of the U.S. District Court for the District of Delaware, the court stated: “10x Genomics (TXG), Inc. and Prognosys Biosciences, Inc. sued NanoString Technologies, Inc.1 ...

Bruker Corp. shows no sign of slowing its buying binge, picking up Nanostring Technologies Inc. for $392.6 million in cash plus the assumption of certain liabilities in its seventh deal so far this ...

* NANOSTRING TECHNOLOGIES-TO USE ABOUT $89.0 MILLION OF NET PROCEEDS TO PREPAY AMOUNTS BORROWED, FEES OWING RELATED TO TERMINATION OF SENIOR TERM LOAN FACILITY * NANOSTRING-TO USE ABOUT $89.0 MILLION ...

NanoString Technologies, the Seattle-based maker of genetic analysis instruments, has collected $2.5 million in new financing, according to a regulatory filing. NanoString's financing, which could be ...

Adds Highly Complementary Business in Gene Expression Profiling and Spatial Transcriptomics for Discovery and Translational Research Under the asset purchase agreement, Bruker has now acquired ...